Chongqing Genrix Biopharmaceutical Co., Ltd. (SHA:688443)
China · Delayed Price · Currency is CNY 31.20
+0.13 (0.42%)
At close: May 12, 2026
SHA:688443 Market Cap
SHA:688443 has a market cap or net worth of 11.44 billion as of May 12, 2026. Its market cap has increased by 9.05% in one year.
Market Cap
11.44B
Enterprise Value
10.49B
Revenue
277.82M
Ranking
n/a
PE Ratio
n/a
Stock Price
31.20
Market Cap Chart
Since June 20, 2023, SHA:688443's market cap has decreased from 12.47B to 11.44B, a decrease of -8.29%. That is a compound annual growth rate of -2.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 11.44B | 14.54% |
| Dec 31, 2025 | 9.99B | 8.57% |
| Dec 31, 2024 | 9.20B | -37.20% |
| Dec 29, 2023 | 14.65B | 17.43% |
| Jun 20, 2023 | 12.47B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| InventisBio | 13.00B |
| Hualan Biological Vaccine | 12.97B |
| Vcanbio Cell & Gene Engineering Corp., | 11.47B |
| Pacific Shuanglin Bio-pharmacy | 11.20B |
| Chengdu Easton Biopharmaceuticals | 11.16B |
| HitGen | 10.98B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 10.25B |
| Daan Gene | 10.25B |